MNX1 and central nervous system cancer: These observations are in line with previous reports describing overexpression of MNX1 in cancers of the colon [15], breast [11,12], prostate [13], and glioma [17], as well as MNX1-AS1 in breast [28], colon [29], oesophageal [30], stomach [31], glioblastoma [32], liver [33], lung [34], ovarian [35,36], and prostate [37] tumours.